L-dopa, behavioral activation and psychopathology.
D000786:Anger / Q000187:drug effects; D000818:Animals; D001143:Arousal / Q000187:drug effects; D001519:Behavior / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects; D001714:Bipolar Disorder / Q000188:drug therapy; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002540:Cerebral Cortex / Q000187:drug effects; D003863:Depression / Q000188:drug therapy*; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D005071:Evoked Potentials; D000882:Haplorhini; D006801:Humans; D007360:Intelligence; D007858:Learning / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy; D010919:Placebos; D011605:Psychoses, Substance-Induced; D012890:Sleep / Q000187:drug effects
D002395:Catecholamines; D010919:Placebos; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine